To assess whether FGFR2 related to first-line anti-cancer drug resistance in GC, cells with either siFGFR2 or siScramble control were treated with escalating concentrations of fluorouracil (5-FU) and cell viability was detected subsequently. The gene discussed is FGFR2; the disease is gastric cancer.